Line 30: |
Line 30: |
| *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] |
| | | |
− | ==Myelodysplastic Syndromes (MDS)== | + | ==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])== |
| | | |
| *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] |
Line 105: |
Line 105: |
| - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| | | |
− | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)== | + | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])== |
| | | |
| *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] |
Line 125: |
Line 125: |
| - [[NK-Lymphoblastic Leukemia/Lymphoma]] | | - [[NK-Lymphoblastic Leukemia/Lymphoma]] |
| | | |
− | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas)== | + | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])== |
| | | |
| *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] |
Line 235: |
Line 235: |
| *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] |
| | | |
− | ==Mature T- and NK-cell Neoplasms== | + | ==[[Mature T- and NK-cell Neoplasms]] (Overview Page Link)== |
| | | |
| *[[T-cell Prolymphocytic Leukemia]] | | *[[T-cell Prolymphocytic Leukemia]] |
Line 297: |
Line 297: |
| *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] |
| | | |
− | ==Hodgkin Lymphomas== | + | ==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])== |
| | | |
| *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] |
Line 308: |
Line 308: |
| - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] |
| | | |
− | ==Immunodeficiency-Associated Lymphoproliferative Disorders== | + | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== |
| | | |
| *[[Lymphomas Associated with HIV Infection]] | | *[[Lymphomas Associated with HIV Infection]] |
Line 323: |
Line 323: |
| *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] |
| | | |
− | ==Histiocytic and Dendritic Cell Neoplasms== | + | ==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== |
| | | |
| *[[Histiocytic Sarcoma]] | | *[[Histiocytic Sarcoma]] |